KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Assets Average (2016 - 2025)

Historic Assets Average for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $4.2 billion.

  • West Pharmaceutical Services' Assets Average rose 1444.69% to $4.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.2 billion, marking a year-over-year increase of 1444.69%. This contributed to the annual value of $4.0 billion for FY2025, which is 589.46% up from last year.
  • Latest data reveals that West Pharmaceutical Services reported Assets Average of $4.2 billion as of Q4 2025, which was up 1444.69% from $4.0 billion recorded in Q3 2025.
  • West Pharmaceutical Services' Assets Average's 5-year high stood at $4.2 billion during Q4 2025, with a 5-year trough of $2.8 billion in Q1 2021.
  • Its 5-year average for Assets Average is $3.5 billion, with a median of $3.6 billion in 2024.
  • As far as peak fluctuations go, West Pharmaceutical Services' Assets Average surged by 2229.89% in 2021, and later crashed by 407.81% in 2024.
  • West Pharmaceutical Services' Assets Average (Quarter) stood at $3.2 billion in 2021, then grew by 7.39% to $3.5 billion in 2022, then grew by 9.38% to $3.8 billion in 2023, then decreased by 3.5% to $3.7 billion in 2024, then rose by 14.45% to $4.2 billion in 2025.
  • Its Assets Average stands at $4.2 billion for Q4 2025, versus $4.0 billion for Q3 2025 and $3.8 billion for Q2 2025.